Primaa
FranceEntry
2020
Hold
6yr
Status
Active
Who owns Primaa?
Primaa is a French Biotech company, currently owned by Odyssée Venture since 2022 and 3 other investors.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Most recent investor
Elaia PartnersElaia Alpha II · 2020 · VC
4 ownership periods · full history below
Key facts
Key takeaways
- ·Co-held by Lazard Elaia Capital, 50 Partners, Elaia Partners and Odyssée Venture since 2019.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected
Active
Co-invest · 4 holders · 2019 · present
Lazard Elaia CapitalActive
2019 · present(7yr) · Elaia Legacy Fund · 2002 · VC
50 PartnersActive
2019 · present(7yr) · 50 Partners Capital Tech · 2014 · VC
Elaia PartnersActive
2020 · present(6yr) · Elaia Alpha II · 2020 · VC
Odyssée VentureActive
2022 · present(4yr) · Odyssee Venture Funds · 1999 · VC
More from Elaia Alpha II
Other portfolio companies in the same fund.
USMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Primaa?
Primaa is currently owned by Odyssée Venture, Elaia Partners and 2 others, through Elaia Alpha II, since 2022.
When did Odyssée Venture and 3 others acquire Primaa?
Odyssée Venture and 3 others acquired Primaa in 2022.
Who has owned Primaa over time?
Primaa has been through 4 private-equity ownership periods: Lazard Elaia Capital · via Elaia Legacy Fund · since 2019; 50 Partners · via 50 Partners Capital Tech · since 2019; Elaia Partners · via Elaia Alpha II · since 2020; Odyssée Venture · via Odyssee Venture Funds · since 2022.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue